Search for: "John Jenkins" Results 1381 - 1400 of 1,811
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Oct 2010, 3:29 am by Bob Kraft
“Meridia’s continued availability is not justified when you compare the very modest weight loss that people achieve on this drug to their risk of heart attack or stroke,” said John Jenkins, M.D., director of the Office of New Drugs in the FDA’s Center for Drug Evaluation and Research (CDER). [read post]